Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid

Clinical trial NCT00172029 · COMPLETED

Trial details

NCT number: NCT00172029
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Breast Cancer With Metastatic Bone Disease

Start date: 2003-04-01
Primary completion: 2005-09-01
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.